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Abstract
Background: Smoking is the most important cause for the development of COPD. Since not all
smokers develop COPD, it is obvious that other factors must be involved in disease development.
We hypothesize that heme oxygenase-1 (HO-1), a protective enzyme against oxidative stress and
inflammation, is insufficiently upregulated in COPD.
The effects of HO-1 modulation on cigarette smoke induced inflammation and emphysema were
tested in a smoking mouse model.
Methods: Mice were either exposed or sham exposed to cigarette smoke exposure for 20 weeks.
Cobalt protoporphyrin or tin protoporphyrin was injected during this period to induce or inhibit
HO-1 activity, respectively. Afterwards, emphysema development, levels of inflammatory cells and
cytokines, and the presence of B-cell infiltrates in lung tissue were analyzed.
Results: Smoke exposure induced emphysema and increased the numbers of inflammatory cells
and numbers of B-cell infiltrates, as well as the levels of inflammatory cytokines in lung tissue. HO-
1 modulation had no effects on smoke induced emphysema development, or the increases in
neutrophils and macrophages and inflammatory cytokines. Interestingly, HO-1 induction prevented
the development of smoke induced B-cell infiltrates and increased the levels of CD4+CD25+ T cells
and Foxp3 positive cells in the lungs. Additionally, the CD4+CD25+ T cells correlated positively
with the number of Foxp3 positive cells in lung tissue, indicating that these cells were regulatory T
cells.
Conclusion: These results support the concept that HO-1 expression influences regulatory T
cells and indicates that this mechanism is involved in the suppression of smoke induced B-cell
infiltrates. The translation of this interaction to human COPD should now be pursued.
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Background
Chronic obstructive pulmonary disease (COPD) is a
major global health problem with increasing morbidity
and mortality. Smoking is widely accepted as the most
important cause for development of the disease, still
'only' 15–20% of the smoking population eventually
develops COPD [1]. COPD is characterized by a chronic
inflammatory process, which ultimately leads to airway
obstruction and emphysema. The important role of neu-
trophils, macrophages and cytotoxic T cells in its develop-
ment is well established [2], yet the role of CD4 T cells and
B cells has only recently re-attracted attention. We and
others have found oligoclonal T- and B cells in the lungs
of COPD patients suggesting an antigen driven immune
response [3,4]. These T-and B cells are aggregated in lym-
phoid infiltrates. Similar infiltrates have been shown in
the lungs of mice chronically exposed to cigarette smoke
[3]. We hypothesize that these lymphoid infiltrates con-
tribute to the development and/or persistence of the
inflammatory response in COPD [3].
Since not all patients with COPD have actively smoked,
cigarette smoke cannot be the sole contributing factor in
COPD development. Other factors involved are genetic
factors, such as α1 anti-trypsin deficiency, and environ-
mental factors, such as air pollution. Another intriguing
factor that may play a role in COPD development is the
'protective' enzyme heme oxygenase-1 (HO-1). HO-1 is
the rate limiting enzyme involved in the breakdown of
heme to equimolar amounts of biliverdin, free iron and
carbon monoxide (CO). HO-1 is rapidly upregulated with
oxidative stress and has potent anti-inflammatory, anti-
apoptotic and anti-proliferative effects [5-7]. The anti-
inflammatory and cytoprotective effects of HO-1 are
mediated by its products, of which in particular CO [8-
10]. Notwithstanding this knowledge, the exact mecha-
nisms behind the protective effects of HO-1 are still
poorly understood.
Interestingly, a reduced HO-1 expression in macrophages
in lung tissue and bronchoalveolar lavage (BAL) in
patients with COPD has been shown [11,12]. In some
people this may be due to a genetic polymorphism in the
HO-1 promoter gene, which causes a lower HO-1 induci-
bility by reactive oxygen species (ROS) [13]. Additionally,
adenoviral mediated HO-1 overexpression in the lung
suppresses porcine pancreatic elastase induced emphy-
sema development in mice [14], again suggesting involve-
ment of HO-1 in emphysema development.
Our general hypothesis is that if HO-1 is insufficiently
upregulated, this contributes to a higher susceptibility to
noxious effects of cigarette smoke and subsequent devel-
opment of COPD. We tested whether HO-1 modulation
in our smoking mouse model [3] influences the develop-
ment of cigarette smoke induced emphysema and lung
inflammation, in particular with respect to lymphoid
infiltrates. We hypothesized that HO-1 induction attenu-
ates cigarette smoke induced emphysema and inflamma-
tion and conversely HO-1 inhibition worsens the noxious
effects of cigarette smoke.
This study showed that long term HO-1 upregulation pre-
vented the development of cigarette smoke induced B-cell
infiltrates, while it had no effect on smoke induced
emphysema and increase in inflammatory cells and
cytokines. Increased numbers of CD4+CD25+ Tregs could




Female A/J mice were divided into six groups (n = 11 per
group); 1. Phosphate buffered saline (PBS) + smoke, 2.
Cobalt protoporphyrin (CoPP) + smoke, 3. Tin protopor-
phyrin (SnPP) + smoke, 4. PBS + sham smoke, 5. CoPP +
sham smoke, 6. SnPP + sham smoke. During 20 weeks the
mice were subjected to protoporphyrin (or PBS) treat-
ment and smoke (or sham smoke) exposure. After 20
weeks the mice were sacrificed, the trachea was cannu-
lated, the right lung was ligated, and lung lobes were
either snap-frozen and stored at -80°C (n = 7) or freshly
used for flow cytometry analysis (n = 7). The left lung was
inflated, and fixed for 24 h with formalin with a constant
pressure of 25 cm H2O (n = 8).
Experiments were approved by the local committee on
animal experimentation.
Smoke exposure
Mice were exposed to 24 puffs of cigarette smoke from
two 2R1 reference cigarettes (University of Kentucky) two
times per day, for 5 days a week during 20 weeks, as
described previously [3].
Protoporphyrin treatment
CoPP and SnPP (Frontier Scientific, Logan, USA) were dis-
solved in 1 M NaOH, diluted to the proper concentration
with PBS and adjusted to pH 7.3–7.5 with HCl. The mice
received a subcutaneous injection with CoPP (25 µM/kg =
16.4 mg/kg) every two weeks, or with SnPP (10 µM/kg =
7.5 mg/kg), or PBS weekly. These concentrations and dos-
ing regimens were based on a pilot, in which different pro-
toporphyrin concentrations were tested for a maximum
period of two weeks.
Morphometrical evaluation of emphysema
Alveolar airspace enlargement was assessed by mean lin-
ear intercept (Lmi) by two independent individuals in a
blinded manner, as described previously [3,15].Respiratory Research 2008, 9:17 http://respiratory-research.com/content/9/1/17
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Cytokines
Frozen lung tissue was homogenized in 50 mM Tris-HCl
buffer, containing 150 mM NaCl, and 0.002% Tween-20
(pH 7.5) and centrifuged at 12000 g for 10 min to remove
any insoluble material. Concentrations of TNF-α, IL-1α,
IL-1β, IL-6, KC (mouse IL-8) and MCP-1 (monocyte che-
moattractant protein-1) in supernatants were measured
with a multiplex ELISA system (Lincoplex Systems, St
Charles, MO, USA).
Flow cytometry
Single-cell leukocyte suspensions were obtained from
lungs for flow cytometric analysis as described previously
[16]. Numbers of CD4+CD25+ T cells and neutrophils
were calculated based on the label combinations: CD3-
APC, CD4-PE, CD25-FITC and Gr1-APC. All antibodies
were obtained from Pharmingen (San Diego, USA).
Histology
HO-1 expression was demonstrated with the rabbit poly-
clonal antibody anti-HO-1 (Stressgen, Victoria, Canada).
Macrophage numbers were identified with an anti-Mac3
antibody (Pharmingen) and were quantified by morpho-
metric analysis using Leica Qwin image analysis software
(Leica Microsystems BV, Rijswijk, the Netherlands). With
this computerized method the total Mac3 positive stained
surface area was measured and divided by the total surface
area lung tissue, and expressed as volume percentages
[16]. B-cell infiltrates were detected with an anti-B220
antibody (Pharmingen). The total surface of the B220
positive infiltrates (clusters of at least 10 cells) was quan-
tified by morphometric analysis and divided by the total
surface area lung tissue, and expressed as volume percent-
ages. Forkhead transcription factor 3 (Foxp3) expression,
a marker for regulatory T cells, was detected in 4 µm sec-
tions of frozen lung tissue by staining with a monoclonal
anti-Foxp3 antibody (Alexis, Breda, the Netherlands). The
total number of Foxp3 positive cells was counted at 25×
magnification and expressed per surface area lung tissue
determined by morphometric analysis. A fluorescent dou-
ble staining with hamster anti mouse-CD3 (Pharmingen),
followed by mouse anti hamster FITC-labeled (eBio-
science) and rat anti mouse-Foxp3 (Alexis) followed by
biotin conjugated goat anti rat (SBA, Birmingen, USA)
and Strep-APC (Pharmingen) was performed on 4 µm fro-
zen sections of spleen and lung tissue to confirm that
Foxp3 positive cells were T cells.
Western blot analysis
HO-1 protein expression was measured with western blot
in whole lung homogenate (see cytokine analysis). The
proteins were separated for molecular weight and blotted
on a nitrocellulose membrane. The membrane was
blocked overnight in 5% skim milk and incubated with
rabbit-anti-HO-1 (Stressgen) followed by a peroxidase
labeled goat-anti-rabbit antibody (DakoCytomation,
Heverlee, Belgium). For protein loading control the mem-
brane was stripped using a 25 mM Glycine-HCl buffer
containing 1% SDS (pH:2) and stained for β-actin (load-
ing control, Abcam, Cambridge, UK) followed by a perox-
idase labeled goat-anti-rabbit antibody
(DakoCytomation). The bands of interest were visualized
using enhanced chemiluminescence according to stand-
ard methods.
Statistics
A multiple linear regression model was used to establish
importance of smoke exposure and protoporphyrin treat-
ment and their possible interactions [17]. First, the model
was tested with the effects of smoking, CoPP treatment,
SnPP treatment, together with the interactions between
smoking and CoPP, and smoking and SnPP. When the
interactions were not significant the model was tested
again without the interaction terms. Afterwards the nor-
mal distribution of the residuals was analyzed and when
needed the data were log or 1/x-transformed to normalize
distributions. A significant interaction signifies that the
effect of the combination is different (larger or smaller)
than the addition of the separate effects of the exposures.
Mann Whitney U tests were used for post-hoc analysis to
test whether significant effects of CoPP and SnPP treat-
ment were present only in smokers or sham smokers or in
both groups. CD4+CD25+ T cells and Foxp3 positive cells
were evaluated with the Spearman correlation. A value of
p < 0.05 was considered significant.
Results
Protoporphyrin treatment and smoking upregulate HO-1 
expression
CoPP resulted in a clear upregulation of HO-1 protein
expression in the lung, particularly in alveolar macro-
phages (Figure 1). Smoking also resulted in an increased
HO-1 protein expression, leading to highest levels of HO-
1 in smoke-exposed mice that also received CoPP. SnPP
resulted in a small increase in HO-1 expression, which
was not affected by smoking.
No effects of HO-1 modulation on smoke induced 
emphysema development
Smoking induced emphysema after 5.5 months smoke
exposure, expressed as a significant increase in mean lin-
ear intercept (Figure 2, p < 0.01). There were no effects of
both protoporphyrins on the mean linear intercept.
Smoking increases the levels of inflammatory cytokines in 
lung tissue
Smoking significantly increased the levels of the pro
inflammatory cytokines TNF-α, IL-1α, IL-1β, IL-6, KC, and
MCP-1 in lung homogenate (Figure 3, p < 0.01). CoPP
increased the levels of IL-6 and KC. Levels of IL-6 were sig-Respiratory Research 2008, 9:17 http://respiratory-research.com/content/9/1/17
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HO-1 protein expression Figure 1
HO-1 protein expression. A: Protein bands for HO-1 (above band) and β-actin (loading control) detected by western blot 
analysis after long term smoke exposure and protoporphyrin treatment. Three animals per group are shown. B: A representa-
tive picture of the HO-1 expression (dark red) in lung tissue is shown for each group (25×). Particularly, alveolar macrophages 
(indicated with a closed arrow) show an increased HO-1 expression after CoPP treatment. The epithelium stains faintly in all 
groups and no differences were observed between the groups. The brown cells (indicated with an open arrow) are pigmented 
macrophages, a result of the smoke exposure. S: smoke, SS: Sham smoke. Mice were divided into 6 groups; 1. Phosphate buff-
ered saline (PBS) + smoke, 2. Cobalt protoporphyrin (CoPP) + smoke, 3. Tin protoporphyrin (SnPP) + smoke, 4. PBS + sham 
smoke, 5. CoPP + sham smoke, 6. SnPP + sham smoke.Respiratory Research 2008, 9:17 http://respiratory-research.com/content/9/1/17
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nificantly increased after CoPP only in the sham smokers
(PBS sham smoke vs. CoPP sham smoke p < 0.05). KC lev-
els were increased after CoPP in both smokers and sham
smokers (PBS sham smoke vs. CoPP sham smoke and PBS
smoke vs. CoPP smoke p < 0.01). In contrast, SnPP
reduced the levels of TNF-α, IL-1α, IL-1β, KC and MCP-1.
Levels of these cytokines were significantly decreased after
SnPP in the sham smokers only (PBS sham smoke vs.
SnPP sham smoke p < 0.05). Additionally, there was a
positive interaction between SnPP and smoking for KC (p
< 0.01) leading to higher KC levels in the SnPP smokers
compared to the SnPP sham smokers.
Smoking increases neutrophils and macrophages in lung 
tissue
Smoking increased the numbers of neutrophils and mac-
rophages in the lung (Figure 4, p < 0.01). There were no
effects of both protoporphyrins on the numbers of neu-
trophils and macrophages.
CoPP treatment prevents cigarette smoke induced B-cell 
infiltrates
Smoking significantly increased the number of B-cell infil-
trates in lung tissue (Figure 5, p < 0.01). In addition, there
was a significant negative interaction between smoking
and CoPP (p < 0.01) signifying that the smoke induced
increase in B-cell infiltrates was reduced in the smoke-
exposed mice that also received CoPP (CoPP smokers).
Reduced number of B-cell infiltrates in CoPP smokers is 
accompanied by increased numbers of CD4+CD25+ T cells 
in lung homogenate
Smoking significantly increased the numbers of
CD4+CD25+ T cells in lung homogenate (Figure 6A, p <
0.01). Additionally, there was a significant positive inter-
action between smoking and CoPP treatment for the
numbers of CD4+CD25+ T cells (p < 0.05), signifying that
the increase of smoking was larger in combination with
CoPP, resulting in the highest numbers of CD4+CD25+ T
cells in the CoPP smokers. This higher expression of CD25
in the CD4+ T-cell population of CoPP smoking compared
to PBS smoking mice is illustrated in Figure 6B.
The increase in CD4+CD25+ T cells represents an increase 
in regulatory T cells
To investigate whether the increased number of
CD4+CD25+ T cells in the CoPP smokers represented an
increase in regulatory T cells (Tregs), we stained lung tis-
sue for the Treg specific marker Foxp3 (Figure 7A). Smok-
ing significantly increased the numbers of Foxp3 positive
cells in lung tissue (Figure 7B, p < 0.01) with a trend (p =
0.07) for a similar effect of CoPP on the number of Foxp3
positive cells. Double staining for CD3 and Foxp3 in lung
and spleen tissue (Figure 7C) showed that Foxp3 positive
cells were indeed T cells. Furthermore, the number of
Foxp3 positive cells in lung tissue correlated positively
with the number of CD4+CD25+ T cells in lung homoge-
nate (ρ = 0.7, p < 0.01).
Discussion
In this study we showed that HO-1 protein upregulation
by CoPP treatment reduced the number of cigarette
smoke induced B-cell infiltrates in mice. These B-cell infil-
trates were similar to the lymphoid follicles found in
COPD patients [3] and are suggested to contribute to
COPD development. The reduced number of B-cell infil-
trates in the CoPP smokers was accompanied by increased
numbers of CD4+CD25+T cells, which most likely are
Tregs. In contrast to our hypothesis, HO-1 upregulation
had no protective effect on cigarette smoke induced
increases in other inflammatory cells and inflammatory
cytokines and subsequent emphysema development.
Additionally, SnPP treatment did not aggravate smoke
induced damage.
We succeeded in long term HO-1 protein upregulation in
our smoking mouse model and to our knowledge this is
the first study using an intervention that leads to long
term HO-1 protein upregulation in vivo. Given the impor-
tance of macrophages and epithelium in the production
of inflammatory mediators after an inflammatory or oxi-
dative stimulus, these cells were carefully evaluated for
their HO-1 expression. In both in vitro and in vivo studies
oxidative stress and cigarette smoke have been shown to
Emphysema development Figure 2
Emphysema development. Mean linear intercept (LMI) 
after long term smoke exposure and protoporphyrin treat-
ment. Smoke groups are represented by closed symbols and 
sham smoke groups by open symbols. * indicates a significant 
effect of smoke exposure (p < 0.05). There were no interac-
tions and no effects of CoPP or SnPP treatment.Respiratory Research 2008, 9:17 http://respiratory-research.com/content/9/1/17
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Inflammatory cytokines in lung homogenate Figure 3
Inflammatory cytokines in lung homogenate. TNF-α, IL-1α, IL-1β, IL-6, KC and MCP-1 levels expressed as pg/g lung 
homogenate after long term smoke exposure and protoporphyrin treatment. Smoke groups are represented by closed sym-
bols and sham smoke groups by open symbols. The significant results of the regression analysis are depicted beneath the fig-
ures. # indicates a significant effect of SnPP treatment (SnPP vs. PBS, post-hoc analysis), and ** indicates a significant effect of 
CoPP treatment (CoPP vs. PBS, post-hoc analysis) (p < 0.05).Respiratory Research 2008, 9:17 http://respiratory-research.com/content/9/1/17
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induce HO-1 expression in pulmonary epithelial cells and
alveolar macrophages [18-21]. Furthermore, HO-1 over-
expression in epithelial cells is protective against oxidative
stress [22]. Indeed, our study showed an increased HO-1
expression after both cigarette smoke exposure and CoPP
treatment. This increased HO-1 expression was highest in
CoPP treated smoking mice and particularly seen in alve-
olar macrophages yet not in epithelial cells. Unfortu-
nately, HO-1 upregulation provided no protective effects
against the smoke induced increases in inflammatory cells
and cytokines, nor did it protect against smoke induced
emphysema. These results do not fit with our hypothesis,
but might be explained in several ways. Firstly, the epithe-
lium did not show an increased HO-1 expression after
CoPP treatment, which still makes it possible for these
cells to respond to cigarette smoke by producing inflam-
matory mediators. In fact, the majority of the inflamma-
tory cytokines that were increased after smoke exposure in
our study can be produced by epithelial cells in response
to cigarette smoke [23-26], which supports this option.
Secondly, contrary to what we had expected, the levels of
IL-6 and KC increased after CoPP treatment in lung tissue,
which may suggest some toxicity of the long term dosing
of CoPP. Given the fact that the majority of the mice
showed irritation of the skin at the injection site after
approximately 4 months of CoPP treatment, the CoPP
dose indeed might have been too high. It is also conceiv-
able that long term exposure to CoPP, much longer than
performed by others, might have other unexpected effects.
For future long term experiments it is probably more
appropriate to use HO-1 transgenic mice, or use less toxic
downstream products of the HO-1 system e.g. CO or
bilirubin. Finally, it was not possible to reliably measure
HO-activity levels on the frozen material available in this
study; a sufficiently sensitive assessment of HO-activity
should certainly be included in future experiments.
SnPP treatment resulted in a slightly increased HO-1 pro-
tein expression, which was not affected by smoke expo-
sure. In contrast to our hypothesis, SnPP treatment did
not aggravate the damaging effects of smoke exposure, but
did decrease the levels of several inflammatory cytokines.
SnPP is known to inhibit the HO-1 activity, while it
increases HO-1 protein expression [27], which supports
the increased HO-1 expression after SnPP treatment in our
study. For SnPP treatment both inflammatory and anti-
inflammatory effects have been described [28-31]. Anti-
inflammatory effects were shown while the HO-1 protein
level was increased but the HO-1 activity downregulated,
suggesting that HO-1 induction by SnPP can have anti-
inflammatory and anti-apoptotic effects independently of
the HO-1 enzyme activity [30,31].
Inflammatory cells in lung tissue Figure 4
Inflammatory cells in lung tissue. Neutrophils and macrophages expressed in lung tissue after long term smoke exposure 
and protoporphyrin treatment. Neutrophils are expressed as numbers per mg lung homogenate. Macrophages are expressed 
as volume percentages. Smoke groups are represented by closed symbols and sham smoke groups by open symbols. The signif-
icant results of the regression analysis are depicted beneath the figures.Respiratory Research 2008, 9:17 http://respiratory-research.com/content/9/1/17
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B-cell infiltrates in lung tissue Figure 5
B-cell infiltrates in lung tissue. A: Volume percentage of B220 positive infiltrates after long term smoke exposure and pro-
toporphyrin treatment. Smoke groups are represented by closed symbols and sham smoke groups by open symbols. The signif-
icant results of the regression analysis are depicted beneath the figure. B: Example of a B-cell infiltrate positive for B220 (red) 
present in lung tissue (50×).
A
BRespiratory Research 2008, 9:17 http://respiratory-research.com/content/9/1/17
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The most important finding of this study was the protec-
tive effect of HO-1 upregulation on the development of
cigarette smoke induced B-cell infiltrates, leading to
reduced numbers of B-cell infiltrates in CoPP treated
smoking mice. The B-cell infiltrates consisted mainly of B
cells surrounded by T cells and were comparable to the B-
cell follicles found in patients with COPD [3]. B cells in
these follicles were found to be oligoclonal in nature [3],
suggesting an antigen driven immune response. Whether
the inflammatory response in COPD is a true antigen spe-
cific response is not fully proven, nor is it clear which anti-
gen(s) may be involved. We consider matrix degradation
products, microbial components, and cigarette smoke
constituents as possible candidates. We hypothesize that
these lymphoid infiltrates contribute to the development
and/or persistence of the inflammatory response in
COPD. This study showed that reduced numbers of B-cell
infiltrates did not prevent smoke induced emphysema
development, which suggests that the presence of B-cell
infiltrates may not be a mandatory prerequisite for
emphysema development in this model. This is compati-
ble with the results of d'Hulst et al, showing smoke
induced emphysema development in scid mice, lacking
functional B- and T-cells [32]. To what extent B cells con-
tribute to the persistence of the inflammatory response in
COPD remains unclear. However, since these mouse
models of cigarette smoke induced emphysema resemble
mild disease, it is also possible that B cells might be more
important in severe than in mild disease. This would be
supported by the data of Hogg et al who found B-cells
especially in GOLD stage 3 and 4 [33].
In this study we extended our previous observations on B-
cell infiltrates [3] by the intriguing finding that the
reduced number of B-cell infiltrates was accompanied by
increased numbers of CD4+CD25+ T cells in the CoPP
smokers. The CD4+CD25+ T-cell population consists of a
mixture of activated T cells and Tregs. Tregs are important
in controlling immunological tolerance and preventing
auto-immune reactions by inhibiting T-cell responses
[34,35]. Dysfunction of Tregs can lead to auto-immune
diseases, allergy, and chronic inflammatory diseases. The
currently best described subset of Tregs is that of the natu-
rally occurring Tregs, expressing high levels of CD25 and
the transcription factor Foxp3 [34].
In this study, the number of CD4+CD25+ T cells correlated
positively with the number of Foxp3 positive cells and the
highest numbers of Foxp3 positive cells were present in
the CoPP smokers with a trend for an effect of CoPP treat-
ment. Together, this suggests that the increase in
CD4+CD25+ T cells in the CoPP smokers represents an
increase in Tregs.
Interestingly, a direct link between Foxp3 and HO-1
expression and function of Tregs was reported recently;
both Foxp3 and HO-1 were shown to be expressed in
Tregs and the suppressive effects of Tregs were shown to
be mediated by HO-1 expression [36]. Furthermore, in a
model of allergic airway inflammation, HO-1 upregula-
tion was shown to increase Treg numbers and their sup-
pressive capacity [37].
Next to their effects on T cells, Tregs can also directly sup-
press B-cell responses without having to suppress the adja-
cent T cells [38,39]. This proves that activated T cells are
not the only target for Tregs and that Tregs can also be
involved in the reduced presence of B-cell infiltrates. Inter-
CD4+ CD25+ T cells in lung tissue Figure 6
CD4+ CD25+ T cells in lung tissue. A: CD4+CD25+ T 
cells expressed as numbers per mg lung tissue after long 
term smoke exposure and protoporphyrin treatment. Smoke 
groups are represented by closed symbols and sham smoke 
groups by open symbols. The significant results of the regres-
sion analysis are depicted beneath the figure. B: Example of 
the flow cytometry analysis: The percentage of CD25 posi-
tive cells within the CD4+ T cell population is shown for a 
PBS (left) and a CoPP (right) smoking mouse.
A
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estingly, chronic cigarette smoke exposure was shown to
increase the numbers of Tregs in the airways of healthy
smokers and smokers with COPD [40], whereas decreased
Treg numbers were found in lung tissue of emphysema
patients [41]. Additionally, we found high numbers of
Foxp3 positive cells present in and surrounding B cell fol-
licles in the lungs of COPD patients (unpublished
results).
Altogether, these findings suggest a role for Tregs in COPD
in the smoke induced inflammatory response, and possi-
bly also B-cell follicle formation, and support the idea that
the HO-1 protein upregulation affected the Treg popula-
tion in our model thereby possibly contributing to the
observed reduced presence of B-cell infiltrates.
Foxp3 positive cells in lung tissue Figure 7
Foxp3 positive cells in lung tissue. A: Foxp3 positive cells (red nuclear staining) present in lung tissue (100×). B: Foxp3 
positive cells expressed as total numbers per mm2 lung tissue after long term smoke exposure and protoporphyrin treatment. 
Smoke groups are represented by closed symbols and sham smoke groups by open symbols. The significant results of the 
regression analysis are depicted beneath the figure, as well as a trend for an effect of CoPP treatment. C: Fluorescent double 
staining for CD3 (green) and Foxp3 (red) in lung (upper panel, 630×) and spleen (lower panel, 400×) showing that Foxp3 spe-
cifically stains T cells. The orange cells in the lung are pigmented macrophages, which show auto fluorescence.Respiratory Research 2008, 9:17 http://respiratory-research.com/content/9/1/17
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Conclusion
Long term HO-1 upregulation prevented the development
of cigarette smoke induced B-cell infiltrates, while it had
no effect on smoke induced emphysema and increase in
neutrophils and macrophages and inflammatory
cytokines. A possible explanation for this effect of HO-1
upregulation on presence of B-cell infiltrates is the
increased presence of CD4+CD25+ Tregs. The exact role of
these Tregs in the smoke induced inflammatory response
has to be elucidated and the translation to human COPD
should now be pursued.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
CB performed the animal experiments, analyzed the data,
performed statistical analysis and drafted the manuscript.
MH participated in the study design and data analysis,
and helped to draft the manuscript. BS participated in the
study design and coordinated and performed the animal
experiments. ML and MG carried out the flow cytometric,
cytokine and immunohistochemical analyses. WT, DP
and DS were involved in the study design and critically
reviewed the manuscript. HK participated in the study
design, was supervisor of the experiments, and helped
with the statistical analyses and writing of the manuscript.
All authors read and approved the final manuscript.
Acknowledgements
The authors thank Nicole Stowell, Anuk Das, and Don Griswold (Cento-
cor, PA, USA) for performing the Luminex assays, Pieter Klok and Mieke 
Versluis for their assistance with sacrificing the mice and the colleagues 
from the Central Animal Facility for performing the smoke exposures.
This work was supported by a Spinoza premium of the Dutch Government 
(Prof. Dr. D.S. Postma) and the Groningen University Institute for Drug 
Exploration (GUIDE).
References
1. National Heart L and Blood Institute, Organization WH: Global
Strategy for Diagnosis, Management, and Prevention of
Chronic Obstructive Pulmonary Disease: NHLBI/WHO
Workshop report, update 2005.  2005.
2. Barnes PJ, Shapiro SD, Pauwels RA: Chronic obstructive pulmo-
nary disease: molecular and cellular mechanisms.  Eur Respir J
2003, 22:672-688.
3. van der Strate BW, Postma DS, Brandsma CA, Melgert BN, Luinge
MA, Geerlings M, Hylkema MN, van den Berg A, Timens W, Kerstjens
HA: Cigarette Smoke-induced Emphysema: A Role for the B
Cell?  Am J Respir Crit Care Med 2006, 173:751-758.
4. Sullivan AK, Simonian PL, Falta MT, Mitchell JD, Cosgrove GP, Brown
KK, Kotzin BL, Voelkel NF, Fontenot AP: Oligoclonal CD4+ T
cells in the lungs of patients with severe emphysema.  Am J
Respir Crit Care Med 2005, 172:590-596.
5. Choi AM, Alam J: Heme oxygenase-1: function, regulation, and
implication of a novel stress-inducible protein in oxidant-
induced lung injury.  Am J Respir Cell Mol Biol 1996, 15:9-19.
6. Otterbein LE, Choi AM: Heme oxygenase: colors of defense
against cellular stress.  Am J Physiol Lung Cell Mol Physiol 2000,
279:L1029-L1037.
7. Otterbein LE, Soares MP, Yamashita K, Bach FH: Heme oxygenase-
1: unleashing the protective properties of heme.  Trends Immu-
nol 2003, 24:449-455.
8. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis
RJ, Flavell RA, Choi AM: Carbon monoxide has anti-inflamma-
tory effects involving the mitogen-activated protein kinase
pathway.  Nat Med 2000, 6:422-428.
9. Slebos DJ, Ryter SW, Choi AM: Heme oxygenase-1 and carbon
monoxide in pulmonary medicine.  Respir Res 2003, 4:7.
10. Song R, Kubo M, Morse D, Zhou Z, Zhang X, Dauber JH, Fabisiak J,
Alber SM, Watkins SC, Zuckerbraun BS, Otterbein LE, Ning W, Oury
TD, Lee PJ, McCurry KR, Choi AMK: Carbon Monoxide Induces
Cytoprotection in Rat Orthotopic Lung Transplantation via
Anti-Inflammatory and Anti-Apoptotic Effects.  Am J Pathol
2003, 163:231.
11. Maestrelli P, Paska C, Saetta M: Decreased haem oxygenase-1
and increased inducible nitric oxide synthase in the lung of
severe COPD patients.  Eur Respir J 2003, 21:971-976.
12. Slebos DJ, Kerstjens HA, Rutgers SR, Kauffman HF, Choi AM, Postma
DS: Haem oxygenase-1 expression is diminished in alveolar
macrophages of patients with COPD.  Eur Respir J 2004,
23:652-653.
13. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara
S, Sasaki H: Microsatellite polymorphism in the heme oxygen-
ase-1 gene promoter is associated with susceptibility to
emphysema.  Am J Hum Genet 2000, 66:187-195.
14. Shinohara T, Kaneko T, Nagashima Y, Ueda A, Tagawa A, Ishigatsubo
Y:  Adenovirus-mediated transfer and overexpression of
heme oxygenase 1 cDNA in lungs attenuates elastase-
induced pulmonary emphysema in mice.  Hum Gene Ther 2005,
16:318-327.
15. Thurlbeck WM: Measurement of pulmonary emphysema.  Am
Rev Respir Dis 1967, 95:752-764.
16. Hylkema MN, Hoekstra MO, Luinge M, Timens W: The strength of
the OVA-induced airway inflammation in rats is strain
dependent.  Clin Exp Immunol 2002, 129:390-396.
17. Altman DG: Practical statistics for medical research London, Chapman &
Hall; 1991. 
18. Fukano Y, Yoshimura H, Yoshida T: Heme oxygenase-1 gene
expression in human alveolar epithelial cells (A549) follow-
ing exposure to whole cigarette smoke on a direct in vitro
exposure system.  Exp Toxicol Pathol 2006, 57:411-418.
19. Fukano Y, Oishi M, Chibana F, Numazawa S, Yoshida T: Analysis of
the expression of heme oxygenase-1 gene in human alveolar
epithelial cells exposed to cigarette smoke condensate.  J Tox-
icol Sci 2006, 31:99-109.
20. Iles KE, Dickinson DA, Wigley AF, Welty NE, Blank V, Forman HJ:
HNE increases HO-1 through activation of the ERK pathway
in pulmonary epithelial cells.  Free Radic Biol Med 2005,
39:355-364.
21. Maestrelli P, El Messlemani AH, De Fina O, Nowicki Y, Saetta M,
Mapp C, Fabbri LM: Increased expression of heme oxygenase
(HO)-1 in alveolar spaces and HO-2 in alveolar walls of
smokers.  Am J Respir Crit Care Med 2001, 164:1508-1513.
22. Lee PJ, Alam J, Wiegand GW, Choi AM: Overexpression of heme
oxygenase-1 in human pulmonary epithelial cells results in
cell growth arrest and increased resistance to hyperoxia.
Proc Natl Acad Sci U S A 1996, 93:10393-10398.
23. Reynolds PR, Cosio MG, Hoidal JR: Cigarette smoke-induced
Egr-1 upregulates proinflammatory cytokines in pulmonary
epithelial cells.  Am J Respir Cell Mol Biol 2006, 35:314-319.
24. Rusznak C, Mills PR, Devalia JL, Sapsford RJ, Davies RJ, Lozewicz S:
Effect of cigarette smoke on the permeability and IL-1beta
and sICAM-1 release from cultured human bronchial epithe-
lial cells of never-smokers, smokers, and patients with
chronic obstructive pulmonary disease.  Am J Respir Cell Mol Biol
2000, 23:530-536.
25. Masubuchi T, Koyama S, Sato E, Takamizawa A, Kubo K, Sekiguchi M,
Nagai S, Izumi T: Smoke extract stimulates lung epithelial cells
to release neutrophil and monocyte chemotactic activity.
Am J Pathol 1998, 153:1903-1912.
26. Wyatt TA, Heires AJ, Sanderson SD, Floreani AA: Protein kinase C
activation is required for cigarette smoke-enhanced C5a-
mediated release of interleukin-8 in human bronchial epithe-
lial cells.  Am J Respir Cell Mol Biol 1999, 21:283-288.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Respiratory Research 2008, 9:17 http://respiratory-research.com/content/9/1/17
Page 12 of 12
(page number not for citation purposes)
27. Sardana MK, Kappas A: Dual control mechanism for heme oxy-
genase: tin(IV)-protoporphyrin potently inhibits enzyme
activity while markedly increasing content of enzyme pro-
tein in liver.  Proc Natl Acad Sci U S A 1987, 84:2464-2468.
28. Sass G, Soares MPY K., Tiegs G: Heme Oxygenase-1 and Its
Reaction Product, Carbon Monoxide, Prevent Inflamma-
tion-Related Apoptotic Liver Damage in Mice.  Hepatology
2003, 38:909-918.
29. Huang TY, Tsai PS, Wang TY, Huang CL, Huang CJ: Hyperbaric
oxygen attenuation of lipopolysaccharide-induced acute lung
injury involves heme oxygenase-1.  Acta Anaesthesiol Scand 2005,
49:1293-1301.
30. Kaizu T, Tamaki T, Tanaka M, Uchida Y, Tsuchihashi S, Kawamura A,
Kakita A: Preconditioning with tin-protoporphyrin IX attenu-
ates ischemia/reperfusion injury in the rat kidney.  Kidney Int
2003, 63:1393-1403.
31. Uchida Y, Tamaki T, Tanaka M, Kaizu T, Tsuchihashi S, Takahashi T,
Kawamura A, Kakita A: Induction of specific stress response
increases resistance of rat liver allografts to cold ischemia
and reperfusion injury.  Transpl Int 2003, 16:396-404.
32. D'hulst AI, Maes T, Bracke KR, Demedts IK, Tournoy KG, Joos GF,
Brusselle GG: Cigarette smoke-induced pulmonary emphy-
sema in scid-mice. Is the acquired immune system required?
Respir Res 2005, 6:147.
33. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cher-
niack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD: The
nature of small-airway obstruction in chronic obstructive
pulmonary disease.  N Engl J Med 2004, 350:2645-2653.
34. Sakaguchi S: Naturally arising Foxp3-expressing CD25+CD4+
regulatory T cells in immunological tolerance to self and
non-self.  Nat Immunol 2005, 6:345-352.
35. Bacchetta R, Gregori S, Roncarolo MG: CD4+ regulatory T cells:
mechanisms of induction and effector function.  Autoimmun Rev
2005, 4:491-496.
36. Choi BM, Pae HO, Jeong YR, Kim YM, Chung HT: Critical role of
heme oxygenase-1 in Foxp3-mediated immune suppression.
Biochem Biophys Res Commun 2005, 327:1066-1071.
37. Xia ZW, Zhong WW, Xu LQ, Sun JL, Shen QX, Wang JG, Shao J, Li
YZ, Yu SC: Heme oxygenase-1-mediated CD4+CD25high reg-
ulatory T cells suppress allergic airway inflammation.  J Immu-
nol 2006, 177:5936-5945.
38. Lim HW, Hillsamer P, Banham AH, Kim CH: Cutting edge: direct
suppression of B cells by CD4+ CD25+ regulatory T cells.  J
Immunol 2005, 175:4180-4183.
39. Lim HW, Hillsamer P, Kim CH: Regulatory T cells can migrate
to follicles upon T cell activation and suppress GC-Th cells
and GC-Th cell-driven B cell responses.  J Clin Invest 2004,
114:1640-1649.
40. Smyth LJ, Starkey C, Vestbo J, Singh D: CD4-regulatory cells in
COPD patients.  Chest 2007, 132:156-163.
41. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S,
Green L, Hacken-Bitar J, Huh J, Bakaeen F, Coxson HO, Cogswell S,
Storness-Bliss C, Corry DB, Kheradmand F: Antielastin autoim-
munity in tobacco smoking-induced emphysema.  Nat Med
2007, 13:567-569.